Understanding early psychosis through biomarkers and specialized care
1/5 - Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)
This study is looking at how early treatment can help young adults aged 18-35 with early signs of psychosis, like schizophrenia or bipolar disorder, by using special tests to understand their unique needs and create better, personalized treatment plans.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-10895398 on NIH RePORTER |
What this research studies
This research investigates how early intervention in psychosis can improve patient outcomes by using biomarkers and clinical data to predict individual illness trajectories. It focuses on patients aged 18-35 with early course psychosis, including conditions like schizophrenia and bipolar disorder with psychosis. By categorizing patients into different biotypes based on EEG, eye movement testing, and neurocognitive assessments, the study aims to tailor treatment plans more effectively. Patients will be followed up at 1, 6, and 12 months to assess their progress and outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are young adults aged 18-35 who are experiencing early symptoms of psychosis.
Not a fit: Patients outside the age range of 18-35 or those not experiencing early psychosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment strategies for individuals experiencing early psychosis.
How similar studies have performed: Previous research has shown promise in using biomarkers for predicting outcomes in psychosis, suggesting that this approach could be effective.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Tamminga, Carol a — Ut Southwestern Medical Center
- Study coordinator: Tamminga, Carol a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.